Overview
Raymond Bergan is an Oncologist in Omaha, Nebraska. Dr. Bergan is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Prostate Cancer, Philadelphia-Negative Chronic Myeloid Leukemia, Triple-Negative Breast Cancer, and Familial Prostate Cancer. Dr. Bergan is currently accepting new patients.
His clinical research consists of co-authoring 64 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Hairy Cell Leukemia (HCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
Locations
987400 Nebraska Medical Ctr, Unmc Physicians Nebraska M, Omaha, NE 68198
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Unmc Physicians
Matthew Lunning is an Oncologist and a Hematologist in Omaha, Nebraska. Dr. Lunning is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Lunning is currently accepting new patients.
Oncology Hematology West, PC
Stefano Tarantolo is a Hematologist Oncology specialist and an Oncologist in Omaha, Nebraska. Dr. Tarantolo is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Tarantolo is currently accepting new patients.
Cancer Partners Of Nebraska PC
Steven Dunder is a Hematologist Oncology specialist and a Hematologist in Lincoln, Nebraska. Dr. Dunder is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Dunder is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Bergan isAdvanced. Learn about Familial Prostate Cancer.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Prostate CancerDr. Bergan isAdvanced. Learn about Prostate Cancer.
- Triple-Negative Breast CancerDr. Bergan isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Bergan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Dr. Bergan isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Bergan isExperienced. Learn about Acute Promyelocytic Leukemia.
- Breast CancerDr. Bergan isExperienced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Bergan isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Bergan isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).